ModeX pipeline progress, 4Kscore reimbursement catalysts, Q2 revenue guidance, cash/buybacks—read key takeaways.

Bipartisan legislative momentum and expanding litigation are accelerating PBM-focused reform at federal and state levels, ...

Q1 2026 earnings call: commercialization timeline, EAP traction, service lab progress, cash runway through 2027 & risks.

FormBlends, a telehealth platform focused on medically supervised GLP-1 therapy and peptide research, today released its 2026 ...

A looming $300 billion patent cliff by 2030 is spurring a surge in biotech M&A, with March 2026 alone seeing $31.5 billion in deals. Analysts highlight CRISPR Therapeutics, Intellia Therapeutics, and ...

Pharmaceutical companies participating in the US Food and Drug Administration (FDA) Quality Maturity Pilot (QMM) program ...

Novel medicines hold promise for patients, but rising costs pose affordability and equity challenges for health systems ...

At the MCAA convention, industry leaders unpacked four trends reshaping commercial mechanical contracting — from megaprojects to workforce challenges — and what they mean for the industry’s future.

Two more drug-making giants will officially start selling popular commercial medications on the White House's discounted pharmaceutical site as soon as Monday, CBS News exclusively learned. American ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

“The Program cannot qualify as a physical taking under the Takings Clause because it does not ‘compel the surrender’ of property, or impose any ‘physical invasion or restraint upon’ it, and the owner ...

AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...